Additionally, the 36-month beta value for ADAP is 2.26. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2
The stock of Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) has increased by 0.23 when compared to last closing price of 0.27. Despite this, the company
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP)’s stock price has gone decline by -20.31 in comparison to its previous close of 0.32, however, the company has
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) has seen a rise in its stock price by 12.89 in relation to its previous close of 0.20. However,
The 36-month beta value for ADAP is at 2.74. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 2
The 36-month beta value for ADAP is also noteworthy at 2.61. There are mixed opinions on the stock, with 4 analysts rating it as a
© 2024, Powered by Smart TechOne